These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up. Prelevic GM; Markou A; Arnold A; Bartram C; Puzigaca Z; Ginsburg J Maturitas; 2004 Mar; 47(3):229-34. PubMed ID: 15036493 [TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures. Pavlov PW; Ginsburg J; Kicovic PM; van der Schaaf DB; Prelevic G; Bennink HJ Gynecol Endocrinol; 1999 Aug; 13(4):230-7. PubMed ID: 10533157 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience. Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620 [TBL] [Abstract][Full Text] [Related]
5. A follow-up study on the effects of a milk supplement on bone mineral density of postmenopausal Chinese women in Malaysia. Ting GP; Tan SY; Chan SP; Karuthan C; Zaitun Y; Suriah AR; Chee WS J Nutr Health Aging; 2007; 11(1):69-73. PubMed ID: 17315084 [TBL] [Abstract][Full Text] [Related]
6. [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal]. Jiang Y; Li M; Xia W; Xing X; Yu W; Tian J; Meng X; Zhou X Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1254-6. PubMed ID: 12425805 [TBL] [Abstract][Full Text] [Related]
7. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196 [TBL] [Abstract][Full Text] [Related]
8. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779 [TBL] [Abstract][Full Text] [Related]
9. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis. Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968 [TBL] [Abstract][Full Text] [Related]
10. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192 [TBL] [Abstract][Full Text] [Related]
11. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover]. Celi M; Balducci S; Schiappoli A; Caliumi C; Petramala L; Cerci S; Cotesta D; D'Erasmo E; Letizia C Ann Ital Med Int; 2003; 18(2):89-98. PubMed ID: 12886826 [TBL] [Abstract][Full Text] [Related]
12. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis. Ruan XY; Jin FY; Liu YL; Peng ZL; Sun YG Chin Med J (Engl); 2008 Jul; 121(13):1155-8. PubMed ID: 18710630 [TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Reginster JY; Bruyère O; Sawicki A; Roces-Varela A; Fardellone P; Roberts A; Devogelaer JP Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207 [TBL] [Abstract][Full Text] [Related]
14. Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss. Rymer J; Robinson J; Fogelman I Osteoporos Int; 2001; 12(6):478-83. PubMed ID: 11446564 [TBL] [Abstract][Full Text] [Related]
15. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years. Love RR; Barden HS; Mazess RB; Epstein S; Chappell RJ Arch Intern Med; 1994 Nov; 154(22):2585-8. PubMed ID: 7979855 [TBL] [Abstract][Full Text] [Related]
16. Benefit period using alendronate to increase bone mineral density in women with osteoporosis? Ozdemir F; Rodoplu M Chin Med J (Engl); 2005 Mar; 118(5):383-90. PubMed ID: 15780207 [TBL] [Abstract][Full Text] [Related]
18. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884 [TBL] [Abstract][Full Text] [Related]
19. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide. Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890 [TBL] [Abstract][Full Text] [Related]
20. Effect of parity on bone mineral density among postmenopausal Saudi Arabian women. Sadat-Ali M; Al-Habdan I; Al-Mulhim AA; El-Hassan AY Saudi Med J; 2005 Oct; 26(10):1588-90. PubMed ID: 16228061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]